vsv-ebov rapidly protects macaques infection / ebola virus outbreak strain
latest ebola virus ebov epidemic spread rapidly guinea sierra leone liberia creating global public health crisis accelerating assessment experimental therapeutics vaccines clinical trials one vaccines based recombinant vesicular stomatitis virus expressing ebov glycoprotein vsv-ebov live-attenuated vector marked preclinical efficacy provide preclinical proof vsv-ebov completely protects macaques lethal challenge west african ebov-makona strain complete partial protection achieved single dose given late days challenge respectively indicates vsv-ebov may protect humans ebov infections west africa relatively short time immunity promoting use immediate public health responses
